RDEA3170 and Febuxostat Drug Interaction Study

NCT01883167 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

21

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: RDEA3170 10 mg
DRUG: Febuxostat 40 mg
DRUG: placebo

Sponsor

Ardea Biosciences, Inc.